Tag Archives: Janssen Pharmaceutica

Feb. 21, 2018—Janssen Pharmaceuticals announced the FDA approval of Erleada (apalutamide) for the treatment of patients with nonmetastic ...

Siemens Healthcare Diagnostics will collaborate with Janssen Pharmaceutica to design, develop, and commercialize a companion diagnostic test associated with an early-stage compound Janssen is developing that targets autoantibodies directed against the human β1-adrenergic receptor that may contribute to the development of heart failure.